ERBB2 and inflammatory breast carcinoma: Nevertheless, a meta-analysis conducted in 2013 by Elias et al. [59] which aimed to identify imaging features of HER2 overexpression in multiple imaging modalities and included IBC lesions next to DCIS lesions, discovered a significant association between HER2 overexpression and high-risk CMDs on mammography.